Skip to main content

Table 1 Patient characteristics

From: High p-Smad2 expression in stromal fibroblasts predicts poor survival in patients with clinical stage I to IIIA non-small cell lung cancer

Characteristic

Number of patients (%)

Patients

78 (100.0)

Median age = 63 years (range 41 to 81)

 

Gender

 

 Male

55 (70.5)

 Female

23 (29.5)

Pathologic type

 

 Squamous carcinoma

41 (52.6)

 Adenocarcinoma

29 (37.2)

 Adenosquamous carcinoma

3 (3.8)

 Large cell carcinoma

5 (6.4)

Pathologic differentiation

 

 High

5 (6.4)

 Median

50 (64.1)

 Low

23 (29.5)

Clinical Stage*

 

 I

20 (25.6)

 II

9 (11.5)

 IIIA

49 (62.9)

Treatment modality - Curative resection

 

 Yes

78 (100.0)

 No

0 (0)

Treatment modality - Adjuvant chemotherapy

 

 Yes

64 (82.1)

 No

14 (17.9)

Treatment modality - Postoperative radiotherapy

 

 Yes

17 (21.8)

 No

61 (78.2)

  1. *According to Union for International Cancer Control/American Joint Committee on Cancer (6th edition) stage system.